Rothé, Françoise
Venet, David
Peeters, Dieter
Rouas, Ghizlane
Rediti, Mattia http://orcid.org/0000-0002-6713-2599
Smeets, Dominiek
Dupont, Floriane
Campbell, Peter
Lambrechts, Diether http://orcid.org/0000-0002-3429-302X
Dirix, Luc
Sotiriou, Christos http://orcid.org/0000-0002-5745-9977
Ignatiadis, Michail http://orcid.org/0000-0002-4493-3748
Funding for this research was provided by:
Fonds De La Recherche Scientifique - FNRS
Fondation contre le cancer; Association Jules Bordet
Breast Cancer Research Foundation
Les Amis de Bordet, MEDIC
Article History
Received: 23 December 2021
Accepted: 10 June 2022
First Online: 5 July 2022
Competing interests
: All the authors declare no non-financial competing interests. The authors C.S. and M.I. declare the following competing financial interests. C.S.: advisory board (receipt of honoraria or consultations fees): Astellas, Cepheid, Vertex, Seattle genetics, Puma, Amgen, Exact Sciences; participation in company sponsored speaker’s bureau: Eisai, Prime Oncology, Teva, Foundation Medicine, Exact Sciences; other support (travel, accommodation expenses): Roche, Genentech, Pfizer. M.I: Consultant/Honoraria: Novartis, Seattle Genetics; research grant to his institution: Roche, Pfizer, Natera Inc. The remaining authors declare no financial competing interests.